TO · PRM.TO
Big Pharma Split Corp.
- Sector
- Financial Services · Asset Management
- Headquarters
- Oakville, ON L6j 4A5
- Website
- harvestportfolios.com
Price · as of 2024-12-31
$13.47
Market cap 18.85M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $1,544.61 | +11,367.04% |
| Intrinsic Value(DCF) | $24.46 | +81.59% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | $6.05 | ||||
| 2018 | $6.36 | $1,497.03 | $35,840,684.61 | $0.00 | $1,381.04 |
| 2019 | $6.97 | $211.12 | $49.13 | $5.81 | $0.00 |
| 2020 | $8.54 | $693.31 | $1,190.17 | $0.00 | $8.95 |
| 2021 | $10.15 | $3,955.13 | $11,764.05 | $3.20 | $297.06 |
| 2022 | $10.50 | $993.97 | $183.74 | $0.00 | $0.00 |
| 2023 | $12.11 | $358.59 | $12.45 | $0.00 | $9.17 |
| 2024 | $12.27 | $1,544.61 | $15,038.83 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Big Pharma Split Corp.'s (PRM.TO) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $1,544.61
- Current price
- $13.47
- AI upside
- +11,367.04%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$24.46
+81.59% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
About Big Pharma Split Corp.
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
- CEO
- Louis Michael Kovacs
- Employees
- 0
- Beta
- 0.56
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($24.46 ÷ $13.47) − 1 = +81.59% (DCF, example).